Skip to main content

Advertisement

Log in

COVID-19 impact on the management of head and neck cancer: a French single-centre experience

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Introduction

The COVID-19 pandemic has caused unprecedented pressure on medical care resources and access. The aim of this study was to evaluate the time between the cancer symptoms’ onset and the first ENT specialist consultation for patients with head and neck (HNC) and salivary glands cancers during the pandemic.

Methods

The outcome measures evaluated were time to diagnosis, and time to treatment onset, as well as the COVID-19 impact on the proportion of both cancer patient groups: asymptomatic and advanced stages. This is single-centre retrospective cross-sectional study, including 473 patients who were treated in our University Hospital for HNC and salivary gland cancers, 171 in the COVID-19 pandemic group (C +), and 302 patients in the pre-pandemic group (C−).

Results

There were no significant between-group differences in the delays between cancer symptoms’ onset and ENT consultation, diagnostic workup and initial treatment onset, respectively. There was a suggestive reduction in the number of diagnostic panendoscopy performed in the C + group (62%) compared to the C- group (73%) as well as a suggestive increase in the delay to adjuvant radiotherapy onset.

Conclusion

The median delay between cancer symptoms’ onset and ENT specialist consultation was not affected by the COVID-19 pandemic in our centre. Our results suggest an 11% decrease in diagnostic procedures performed independently, a decrease in the delay between the ENT consultation and surgical treatment onset and a 10-day increase in the delay to adjuvant radiotherapy onset.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

Data available on request.

References

  1. Bray F, Ferlay J, Soerjomatan I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA J Clin 68:394–424. https://doi.org/10.3322/caac.21492

    Article  Google Scholar 

  2. Graboyes EM, Kompelli AR, Neskey DM et al (2019) Association of treatment delays with survival for patients with head and neck cancer: a systematic review. JAMA Otolaryngol Head Neck Surg. 145(2):166–177. https://doi.org/10.1001/jamaoto.2018.2716

    Article  PubMed  PubMed Central  Google Scholar 

  3. Dong E, Du H, Gardner L (2020) An interactive web-based dashboard to track Covid-19 in real time. Lancet Infect Dis 20(5):533–534. https://doi.org/10.1016/S1473-3099(20)30120-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Fakhry N, Schultz P, Morinière S et al (2020) French consensus on management of head and neck cancer surgery during COVID-19 pandemic. Eur Ann Otorhinolaryngol Head Neck Dis 137(3):159–160. https://doi.org/10.1016/j.anorl.2020.04.008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Heimes D, Muller LK, Schellin A et al (2021) Consequences of the Covid-19 pandemic and governmental containment policies on the detection and therapy of oral malignant lesions-a retrospective, multicenter cohort study from Germany. Cancers 13(12):2892. https://doi.org/10.3390/cancers13122892

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Peacock HM, Tambuyzer T, Verdoodt F et al (2021) Decline and incomplete recovery in cancer diagnoses during the Covid-19 pandemic in Belgium: a year-long, population-level analysis. Eur Soc Med Oncol 6(4):100197. https://doi.org/10.1016/j.esmoop.2021.100197

    Article  CAS  Google Scholar 

  7. Sandhu P, Grossman S, Beneng K (2021) The impact of cessation of primal dental care services on oral cancer diagnosis at a single institution in the UK’s epicentre during the COVID-19 pandemic. Oral Surg 14(4):328–334. https://doi.org/10.1111/ors.12626

    Article  PubMed  PubMed Central  Google Scholar 

  8. Paleri V, Hardman J, Tikka T et al (2020) Rapid implementation of an evidence-based remote triaging system for assessment of suspected referrals and patients with head and neck cancer on follow-up after treatment during the COVID-19 pandemic: model for international collaboration. Head Neck 42(7):1674–1680. https://doi.org/10.1002/hed.26219

    Article  PubMed  PubMed Central  Google Scholar 

  9. Singh AK, Kasle DA, Jiang R et al (2020) A review of telemedicine, applications in otorhinolaryngology: considerations during the coronavirus disease of 2019 pandemic. Laryngoscope 131(4):744–759. https://doi.org/10.1002/lary.29131

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Mehanna H, Hardman JC, Shenson JA et al (2020) Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus. The lancet 21(7):350–359. https://doi.org/10.1016/S1470-2045(20)30334-X

    Article  Google Scholar 

  11. Murphy CT, Galloway TJ, Handorf EA et al (2015) Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol 34(2):169–178. https://doi.org/10.1200/JCO.2015.61.5906

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Rygalski CJ, Zhao S, Eskander A et al (2021) Time to surgery and survival in head and neck cancer. Ann Surg Oncol 28(2):877–885. https://doi.org/10.1245/s10434-020-09326-4

    Article  PubMed  Google Scholar 

  13. Von Elm E, Altman DG, Egger M et al (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453–1457. https://doi.org/10.1016/S0140-6736(07)61602-X

    Article  Google Scholar 

  14. Ionannidis JPA (2018) The proposal to lower P value thresholds to .005. JAMA. 319(14):1429–1430. https://doi.org/10.1001/jama.2018.1536

    Article  Google Scholar 

  15. Laccourreye O, Fakhry N, Franco-Vidal V et al (2020) Statistics in scientific articles published in the European Annals of Otorhinolaryngology Head and Neck Diseases, European Annals of Otorhinolaryngology. Head and Neck diseases 138(2):89–92. https://doi.org/10.1016/j.anorl.2020.06.015

    Article  Google Scholar 

  16. Stevens MN, Patro A, Rashman B et al (2022) Impact of COVID-19 on presentation, staging and treatment of head and neck mucosal squamous cell carcinoma. Am J Otorhinolaryngol-Head Neck Med Surg 43(1):103263. https://doi.org/10.1016/j.amjoto.2021.103263

    Article  CAS  Google Scholar 

  17. Tan H, Preston J, Hunn S et al (2021) COVID-19 did not delay time from referral to definitive management for head and neck cancer patients in a regional Victorian center. ANZ J Surg 91(7–8):1364–1368. https://doi.org/10.1111/ans.17057

    Article  PubMed  PubMed Central  Google Scholar 

  18. Tevetoglu F, Kara S, Aliyeva C et al (2021) Delayed presentation of head and neck cancer patients during COVID-19 pandemic. Eur Arch Otorhinolaryngol 278(12):5081–5085. https://doi.org/10.1007/s00405-021-06728-2

    Article  PubMed  PubMed Central  Google Scholar 

  19. Metzger K, Mrosek J, Zittel S et al (2021) Treatment delay and tumor size in patients with oral cancer during the first year of the COVID-19 pandemic. Head Neck 43(11):3493–3497. https://doi.org/10.1002/hed.26858

    Article  PubMed  PubMed Central  Google Scholar 

  20. Laccourreye O, Mirghani H, Evrard D et al (2020) Impact of the first month of Covid-19 lockdown on oncologic surgical activity in the Ile de France region university hospital otorhinolaryngology departments. Eur Ann Otolaryngol Head Neck Dis 137(4):273–276. https://doi.org/10.1016/j.anorl.2020.06.007

    Article  CAS  Google Scholar 

  21. Kiong KL, Diaz EM, Gross ND et al (2021) The impact of COVID-19 on head and neck cancer diagnosis and disease extent. Head Neck 43(6):1890–1897. https://doi.org/10.1002/hed.26665

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ruiz-Medina S, Gil S, Jimenez B et al (2021) Significant decrease in annual cancer diagnoses in Spain during the COVID-19 pandemic: a real-data study. Cancers 13(13):3215. https://doi.org/10.3390/cancers13133215

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Taylor R, Omakobia E, Sood S et al (2020) The impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary center study. J Laryngol Otol 134(8):684–687. https://doi.org/10.1017/S0022215120001735

    Article  CAS  PubMed  Google Scholar 

  24. De Luca P, Bisogno A, Colacurcio V et al (2022) Diagnosis and treatment delay of head and neck cancers during COVID-19 era in a tertiary care academic hospital: what should we expect? Eur Arch Otorhinolaryngol 279(2):961–965. https://doi.org/10.1007/s00405-021-06834-1

    Article  PubMed  Google Scholar 

  25. Hale T, Angrist N, Goldszmidt R et al (2021) A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nat Hum Behav 5(4):529–538. https://doi.org/10.1038/s41562-021-01079-8

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Dr Clodic Coralie for the study project.

Funding

No funding was provided for this study.

Author information

Authors and Affiliations

Authors

Contributions

MC, CC and AS: for data collection, MR and LJC: for the statistical analysis, MC: for the writing process and ZA: for data interpretation and intellectual content editing.

Corresponding author

Correspondence to Maheo Clementine.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Ethical approval

This study was approved by the Institutional Ethics Committee (Brest Ethics Committee) (protocol number 29BRC21.0372). The research was conducted ethically, with all study procedures being performed in accordance with the requirements of the World Medical Association’s Declaration of Helsinki.

Informed consent

Written informed consent was obtained from each participant/patient for study participation and data publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Clementine, M., Camille, C., Swann, A. et al. COVID-19 impact on the management of head and neck cancer: a French single-centre experience. Eur Arch Otorhinolaryngol 281, 873–882 (2024). https://doi.org/10.1007/s00405-023-08245-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-023-08245-w

Keywords

Navigation